What action is a healthcare provider likely to take for a client on simvastatin who plans to get pregnant?

For a client on simvastatin who is planning to become pregnant, a healthcare provider is likely to consider the safety profile of simvastatin during pregnancy. Simvastatin is classified as a category X medication by the FDA, meaning it is contraindicated in pregnancy due to potential harm to the fetus. Thus, while it is essential to manage cholesterol levels, the provider would prioritize the health of both the mother and the developing fetus.

In this context, prescribing a bile acid sequestrant is a suitable action. Bile acid sequestrants, such as cholestyramine, are considered safer alternatives during pregnancy as they have not been associated with teratogenic effects. This allows for cholesterol management without compromising the client's safety and that of the pregnancy.

When evaluating the other options, increasing the dosage of simvastatin would present unnecessary risks, as higher doses could potentially lead to more significant fetal risks. Prescribing a different statin might still pose teratogenic risks, as many statins carry similar warnings regarding pregnancy. Lastly, making no medication change would disregard the vital need for safety adjustments prior to conception.